美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
62756-568-86	62756-568	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20191202	N/A	ANDA	ANDA209782	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	125 mg/1	60 TABLET, FOR SUSPENSION in 1 BOTTLE (62756-568-86)
62756-568-83	62756-568	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20191202	N/A	ANDA	ANDA209782	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	125 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (62756-568-83)
62756-570-83	62756-570	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20191202	N/A	ANDA	ANDA209782	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	500 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (62756-570-83)
62756-569-86	62756-569	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20191202	N/A	ANDA	ANDA209782	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	250 mg/1	60 TABLET, FOR SUSPENSION in 1 BOTTLE (62756-569-86)
62756-569-83	62756-569	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20191202	N/A	ANDA	ANDA209782	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	250 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (62756-569-83)
62756-570-86	62756-570	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20191202	N/A	ANDA	ANDA209782	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	500 mg/1	60 TABLET, FOR SUSPENSION in 1 BOTTLE (62756-570-86)